umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
TGF-beta uses the E3-ligase TRAF6 to turn on the kinase TAK1 to kill prostate cancer cells
Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Ludwig Institute for Cancer Research, Uppsala University, Sweden.
Ludwig Institute for Cancer Research, Uppsala University, Uppsala, Sweden.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
2009 (English)In: Future oncology (London, England), ISSN 1744-8301, Vol. 5, no 1, 1-3 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2009. Vol. 5, no 1, 1-3 p.
Identifiers
URN: urn:nbn:se:umu:diva-36643DOI: 10.2217/14796694.5.1.1PubMedID: 19243289OAI: oai:DiVA.org:umu-36643DiVA: diva2:355456
Available from: 2010-10-06 Created: 2010-10-06 Last updated: 2011-09-02Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Landström, Maréne
By organisation
Pathology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 158 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf